CytoDyn Inc. Price-FCF Ratio
The price-to-free-cash-flow (P/FCF) ratio tells you how many dollars investors pay for each dollar of cash a company generates after paying for its capital spending. It is market capitalization divided by free cash flow over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher ratio means investors are paying more for each dollar of free cash flow; a negative ratio means the company spent more cash than it generated over those quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.
- CytoDyn Inc. price-fcf ratio for the quarter ending 2022-02-28 was -3.48, a change of 20.63 year-over-year.
- CytoDyn Inc. price-fcf ratio for the quarter ending 2021-11-30 was -7.31, a change of 7.26 year-over-year.
- CytoDyn Inc. price-fcf ratio for the quarter ending 2021-08-31 was -8.19, a change of 12.04 year-over-year.
- CytoDyn Inc. price-fcf ratio for the quarter ending 2021-05-31 was -10.1, a change of 12.21 year-over-year.
- CytoDyn Inc. price-fcf ratio for fiscal 2022 was -3.48.
- CytoDyn Inc. price-fcf ratio for fiscal 2021 was -7.31, a change of 7.26 from fiscal 2020.
- CytoDyn Inc. price-fcf ratio for fiscal 2020 was -14.58, a change of -12.58 from fiscal 2019.
- CytoDyn Inc. price-fcf ratio for fiscal 2019 was -1.99.
- Available history
- 2011-05-31 to 2022-02-28
- Data captured